Inventor · disambiguated record
Michael T. Trese
Also filed as: TRESE MICHAEL T · TRESE MICHAEL THOMAS
17 granted patents·6 pending applications·338 citations·filing 1992–2021
93Inventor score
Files withRETINAL SOLUTIONS LLC9NUVUE TECHNOLOGIES INC4TRESE MICHAEL T3NUVUE TECHNOLOGIES L L C2BEAUMONT HOSPITAL WILLIAM1
Top patents by PatentIndex Score
23 records- 0188US6183692B1Kit for purification of plasminFiled 2000·Granted Feb 6, 2001·24 cites·5 claims
- 0286US6787135B2Modification of vitreal matrix metalloproteinase activityBEAUMONT HOSPITAL WILLIAM·Filed 2002·Granted Sep 7, 2004·22 cites·18 claims
- 0381US10669321B2Retinal capillary regeneration with synthetic norrin proteinRETINAL SOLUTIONS LLC·Filed 2018·Granted Jun 2, 2020·1 cites·9 claims
- 0480US6207066B1Method for purification of a blood componentNUVUE TECHNOLOGIES L L C·Filed 1998·Granted Mar 27, 2001·41 cites·15 claims
- 0577US7776026B2Method for vitreous liquefactionNUVUE TECHNOLOGIES INC·Filed 2002·Granted Aug 17, 2010·8 cites·24 claims
- 0675US5304118AMethod for performing a vitrectomy on an eyeTRESE MICHAEL T·Filed 1992·Granted Apr 19, 1994·147 cites·7 claims
- 0769US10202429B2Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edemaRETINAL SOLUTIONS LLC·Filed 2015·Granted Feb 12, 2019·1 cites·13 claims
- 0868US10206978B2Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edemaRETINAL SOLUTIONS LLC·Filed 2015·Granted Feb 19, 2019·1 cites·9 claims
- 0967US6428553B1Illuminated ophthalmic membrane pick assemblyNUVUE TECHNOLOGIES INC·Filed 2000·Granted Aug 6, 2002·48 cites·8 claims
- 1061US11198714B2Synthetic truncated norrin proteinRETINAL SOLUTIONS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·10 claims
- 1158US10799557B2Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edemaRETINAL SOLUTIONS LLC·Filed 2018·Granted Oct 13, 2020·0 cites·14 claims
- 1257US10703787B2Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edemaRETINAL SOLUTIONS LLC·Filed 2018·Granted Jul 7, 2020·0 cites·13 claims
- 1354US2010211408A1Systems and methods for generating medical diagnosesPARK CARL HYUNSUK·Filed 2009·Application pending·0 cites
- 1453US6855263B2Rapid process for purification and concentration of plasminNUVUE TECHNOLOGIES INC·Filed 2002·Granted Feb 15, 2005·5 cites·23 claims
- 1553US2023126239A1Norrin regulation of plasmalemma vesicle-associated protein and use to treat macular degenerationRETINAL SOLUTION LLC·Filed 2021·Application pending·0 cites
- 1652US2024000890A1Neural regeneration with synthetic protein administrationRETINAL SOLUTIONS LLC·Filed 2021·Application pending·0 cites
- 1750US11041863B2Frizzled-4 mutation indicator of retinopathy and intrauterine growth restrictionRETINAL SOLUTIONS LLC·Filed 2017·Granted Jun 22, 2021·0 cites·7 claims
- 1850US2006024349A1Method for creating a separation of posterior cortical vitreous from the retina of the eyeNUVUE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 1947US2016022769A1Compostions and methods for treating retinal diseaseTRESE MICHAEL T·Filed 2013·Application pending·0 cites
- 2045US12485158B2Norrin induced expression of genes and use thereof to treat diseaseRETINAL SOLUTIONS LLC·Filed 2018·Granted Dec 2, 2025·0 cites·10 claims
- 2145US2002139378A1Method for creating a separation of posterior cortical vitreous from the retina of the eyeFiled 2001·Application pending·0 cites
- 2244US6083155AEyelid speculumNUVUE TECHNOLOGIES L L C·Filed 1999·Granted Jul 4, 2000·40 cites·6 claims
- 2338US9622657B2Automated system for measurement of zone 1 in assessment of severity of retinopathy of prematurityTRESE MICHAEL T·Filed 2015·Granted Apr 18, 2017·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Michael T. Trese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →